Thursday, 25 April 2024
Windtree Therapeutics Inc.
11:41 | 15/11/17
PR Newswire
14, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported financial results for the third quarter ended September 30, ...
more»
08:26 | 22/8/17
PR Newswire
21, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported financial results for the second quarter ended June 30, ...
more»
04:41 | 5/7/17
Insider Financial
The company is Windtree Therapeutics Inc (OTCMKTS:WINT) and the trial that just completed was a phase IIb study investigating the company's lead development asset - a drug called aerosolized KL4 surfactant - In a target indication of respiratory ...
more»
12:11 | 1/7/17
BioWorld Online
Clogged cartridge filters and the trial failure they likely caused battered shares of Windtree Therapeutics Inc. (OTCQB:WINT), sending the stock falling 61.8 percent Friday, or 53 cents, to close at 33 cents on news that its aerosolized medicine for ...
more»
05:37 | 20/6/17
Stock Daily Review
Shares of Windtree Therapeutics Inc (WINT) is moving on volatility today 1.49% or 0.013 rom the open. The OTC listed company saw a recent bid of 0.8830 on 16933 volume.
more»
00:56 | 18/6/17
Stock Daily Review
TearLab Corporation (NasdaqCM:TEAR) currently has a Value Composite score of 92. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.
more»
06:33 | 17/6/17
Concord Register
Shares of Windtree Therapeutics Inc (WINT) is moving on volatility today -5.56% or -0.05 rom the open. The OTC listed company saw a recent bid of 0.8500 on 1247 volume.
more»
08:03 | 13/6/17
PR Newswire
WARRINGTON, Pa. and SHATIN, Hong Kong, June 12, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, and Lee's ...
more»
08:03 | 2/6/17
PR Newswire
WARRINGTON, Pa., June 1, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced completion of enrollment in its ...
more»
08:06 | 23/5/17
PR Newswire
WARRINGTON, Pa., May 22, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has been awarded $0.9 ...
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |